Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05095506 · ClinicalTrials.gov registry record · NA

Evaluation of an eHealth System to Reduce Depression and Increase Resilience After SCI

A NA study of Spinal Cord Injuries, sponsored by University of Delaware.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT05095506: Completed NA study of Spinal Cord Injuries, sponsored by University of Delaware.

NCT05095506 is a NA study of Spinal Cord Injuries that has completed, run by University of Delaware. The registered enrollment target is 160 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (162% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05095506, a NA study of Spinal Cord Injuries, has completed, sponsored by University of Delaware.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The availability of symptom monitoring and self-management (SMSM) interventions is especially important for civilians and military populations with spinal cord injuries (SCI). High rates of depressive disorders (20-40%) and anxiety disorders (20-25%) have been found in both civilian and military populations and are significant contributors to both quality of life and well-being after SCI. Previous self-management interventions targeting physical activity and self-reliance in individuals with SCI have demonstrated significant health and lifestyle benefits. However, it has been shown that the injured individual's psychological outlook and mood can either enable or hinder self-management efforts and that currently available SCI-specific self-management programs may be inadequate. Developing interventions to reduce mental health symptoms following SCI is therefore critical to improve the lives of individuals, alleviate resource strain on military and civilian health care systems, and potentially reduce the rate of mortality by suicide in Veterans and civilians living with SCI. The current study will build on prior work developing an intervention platform to assess the effectiveness of this eHealth SMSM system and will test the feasibility and effectiveness of the intervention platform.

Primary Outcome

Patient-reported outcome measure of current depressive symptoms which is included in the intervention and control conditions each week.

Conditions Studied

Interventions

  • OTHER eHealth Intervention
  • OTHER Active Control Condition

Study Locations (1)

Delaware

  • University of Delaware College of Health Sciences - Newark

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2023-11-08
Est. Completion 2024-11-24
Phase NA
University of Delaware

106 total trials

What the finished NCT05095506 record still lists

NCT05095506 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (162% higher).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which eHealth Intervention is the first listed.

NCT05095506 reports a single indexed study location in Delaware.

Frequently Asked Questions

What is clinical trial NCT05095506 about?

NCT05095506 is a clinical study titled "Evaluation of an eHealth System to Reduce Depression and Increase Resilience After SCI". The availability of symptom monitoring and self-management (SMSM) interventions is especially important for civilians and military populations with spinal cord injuries (SCI). High rates of depressive disorders (20-40%) and anxiety disorders (20-25%) have been found in both civilian and military pop...

What is the current status of trial NCT05095506?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2023-11-08. Estimated completion is 2024-11-24.

What conditions does trial NCT05095506 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT05095506?

The interventions under investigation include: eHealth Intervention (OTHER), Active Control Condition (OTHER).

Who is sponsoring clinical trial NCT05095506?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05095506 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05095506's enrollment target sits among peer trials

160 17th of 202 higher than 184 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05095506, the US trial registry maintained by the National Library of Medicine. NCT05095506 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.